Literature DB >> 29074716

Antimicrobial resistance in UK neonatal units: neonIN infection surveillance network.

Benjamin Cailes1, Christina Kortsalioudaki1, Jim Buttery2, Santosh Pattnayak3, Anne Greenough4, Jean Matthes5, Alison Bedford Russell6, Nigel Kennea7, Paul T Heath1.   

Abstract

OBJECTIVE: To define the susceptibilities of the common causative pathogens of neonatal sepsis in the UK.
DESIGN: Retrospective analysis of the prospectively collected neonIN infection surveillance network data between 2005 and 2014.
SETTING: 30 neonatal units in the UK. PATIENTS: Newborns admitted to participating neonatal units who return a positive blood, cerebrospinal fluid or urine culture and are treated with at least 5 days of appropriate antibiotics.
RESULTS: 1568 isolates with recorded antimicrobial data were collected including 328 early-onset sepsis (EOS) isolates and 1240 late-onset sepsis (LOS) isolates. The majority of EOS pathogens (>92%) were susceptible to the four empirical commonly used antimicrobial combinations (eg, 93% for benzylpenicillin/gentamicin), while LOS pathogens demonstrated higher levels of resistance (eg, 89% for flucloxacillin/gentamicin). Among infants<1500 g and <32 weeks gestation, an amoxicillin/gentamicin combination demonstrated a trend towards improved coverage of EOS isolates than benzylpenicillin/gentamicin (93% vs 86%, p=0.211).
CONCLUSIONS: This analysis provides insights into the patterns of antimicrobial resistance among UK neonatal pathogens. These data will inform areas of future research and can be used to update national evidence-based guidelines on antimicrobial usage. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  epidemiology; infectious diseases; intensive care; neonatology

Mesh:

Substances:

Year:  2017        PMID: 29074716     DOI: 10.1136/archdischild-2017-313238

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

Review 1.  Drugs for the Prevention and Treatment of Sepsis in the Newborn.

Authors:  Sagori Mukhopadhyay; Kelly C Wade; Karen M Puopolo
Journal:  Clin Perinatol       Date:  2019-03-30       Impact factor: 3.430

2.  Early-onset neonatal sepsis and antibiotic use in Indonesia: a descriptive, cross-sectional study.

Authors:  Khansa Salsabila; Nadira Mohammad Ali Toha; Lily Rundjan; Porjai Pattanittum; Prapassara Sirikarn; Rinawati Rohsiswatmo; Setya Wandita; Mohammad Hakimi; Pagakrong Lumbiganon; Sally Green; Tari Turner
Journal:  BMC Public Health       Date:  2022-05-17       Impact factor: 4.135

3.  Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.

Authors:  Marine Butin; Frédéric Laurent; Thierry Wirth; Marine Bergot; Jean-Philippe Rasigade; Bruno Pichon; Maxime Barbier; Patricia Martins-Simoes; Laurent Jacob; Rachel Pike; Pierre Tissieres; Jean-Charles Picaud; Angela Kearns; Philip Supply
Journal:  Nat Microbiol       Date:  2020-04-27       Impact factor: 17.745

4.  A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009-2018 at Tygerberg Hospital, South Africa.

Authors:  Kessendri Reddy; Adrie Bekker; Andrew C Whitelaw; Tonya M Esterhuizen; Angela Dramowski
Journal:  PLoS One       Date:  2021-01-14       Impact factor: 3.240

5.  Early-Onset Sepsis in Neonates - A Population-Based Study in South-West Norway From 1996 to 2018.

Authors:  Anlaug Vatne; Claus Klingenberg; Siren Rettedal; Knut Øymar
Journal:  Front Pediatr       Date:  2021-03-17       Impact factor: 3.418

6.  Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019.

Authors:  Jing Liu; Zengyu Fang; Yonghui Yu; Yanjie Ding; Zhijie Liu; Chengyuan Zhang; Haiying He; Hongli Geng; Weibing Chen; Guoying Zhao; Qiang Liu; Baoying Wang; Xueming Sun; Shaofeng Wang; Rongrong Sun; Delong Fu; Xinjian Liu; Lei Huang; Jing Li; Xuexue Xing; Xiaokang Wang; Yanling Gao; Renxia Zhu; Meiying Han; Fudong Peng; Min Geng; Liping Deng
Journal:  Antimicrob Resist Infect Control       Date:  2021-08-16       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.